{"id":"https://openalex.org/W2007348690","doi":"https://doi.org/10.1159/000008084","title":"Escalating Immunotherapy of Multiple Sclerosis","display_name":"Escalating Immunotherapy of Multiple Sclerosis","alternate_titles":[],"publication_year":1999,"publication_date":"1999-10-08","ids":{"openalex":"https://openalex.org/W2007348690","doi":"https://doi.org/10.1159/000008084","mag":"2007348690","pmid":"https://pubmed.ncbi.nlm.nih.gov/10529535"},"language":"en","primary_location":{"id":"doi:10.1159/000008084","doi":"https://doi.org/10.1159/000008084","is_oa":false,"landing_page_url":"https://doi.org/10.1159/000008084","pdf_url":null,"source":{"id":"https://openalex.org/S162735375","display_name":"European Neurology","issn_l":"0014-3022","issn":["0014-3022","1421-9913"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-3","vabb-shw"],"host_organization":"https://openalex.org/P4310317820","host_organization_name":"Karger Publishers","host_organization_lineage":["https://openalex.org/P4310317820"],"host_organization_lineage_names":["Karger Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Neurology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2007348690"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"P. Rieckmann","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I25974101","display_name":"University of W\u00fcrzburg","ror":"https://ror.org/00fbnyb24","country_code":"DE","type":"education","lineage":["https://openalex.org/I25974101"]},{"id":"https://openalex.org/I4210126310","display_name":"Universit\u00e4tsklinikum W\u00fcrzburg","ror":"https://ror.org/03pvr2g57","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I4210126310"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"P. Rieckmann","raw_affiliation_strings":["Klinische Forschungsgruppe f\u00fcr Multiple Sklerose und Neuroimmunologie, Neurologische Universit\u00e4tsklinik, W\u00fcrzburg, Deutschland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Klinische Forschungsgruppe f\u00fcr Multiple Sklerose und Neuroimmunologie, Neurologische Universit\u00e4tsklinik, W\u00fcrzburg, Deutschland","institution_ids":["https://openalex.org/I25974101","https://openalex.org/I4210126310"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5036256132","display_name":"Klaus Victor Toyka","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I25974101","display_name":"University of W\u00fcrzburg","ror":"https://ror.org/00fbnyb24","country_code":"DE","type":"education","lineage":["https://openalex.org/I25974101"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"K.V. Toyka","raw_affiliation_strings":["Dept. of Neurology, W\u00fcrzburg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dept. of Neurology, W\u00fcrzburg, Germany","institution_ids":["https://openalex.org/I25974101"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":2.95,"has_fulltext":false,"cited_by_count":46,"citation_normalized_percentile":{"value":0.89821251,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":95},"biblio":{"volume":"42","issue":"3","first_page":"121","last_page":"127"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10137","display_name":"Multiple Sclerosis Research Studies","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10137","display_name":"Multiple Sclerosis Research Studies","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10469","display_name":"Psoriasis: Treatment and Pathogenesis","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11827","display_name":"Polyomavirus and related diseases","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/multiple-sclerosis","display_name":"multiple sclerosis","score":0.9990000128746033},{"id":"https://openalex.org/keywords/immunotherapy","display_name":"immunotherapy","score":0.7870000004768372},{"id":"https://openalex.org/keywords/immunomodulatory-therapy","display_name":"immunomodulatory therapy","score":0.8500000238418579},{"id":"https://openalex.org/keywords/relapse-reduction","display_name":"relapse reduction","score":0.7940000295639038},{"id":"https://openalex.org/keywords/treatment-uptake","display_name":"treatment uptake","score":0.5559999942779541},{"id":"https://openalex.org/keywords/consensus-report","display_name":"consensus report","score":0.6000000238418579},{"id":"https://openalex.org/keywords/treatment-strategy","display_name":"treatment options","score":0.6370000243186951}],"concepts":[{"id":"https://openalex.org/C2780640218","wikidata":"https://www.wikidata.org/wiki/Q8277","display_name":"Multiple sclerosis","level":2,"score":0.8358888626098633},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6662864685058594},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.5725967288017273},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.5566874146461487},{"id":"https://openalex.org/C154775046","wikidata":"https://www.wikidata.org/wiki/Q188","display_name":"German","level":2,"score":0.4978930950164795},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.47973623871803284},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.45582613348960876},{"id":"https://openalex.org/C3017605391","wikidata":"https://www.wikidata.org/wiki/Q1021509","display_name":"Consensus conference","level":2,"score":0.41040271520614624},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.2146340012550354},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.20908966660499573},{"id":"https://openalex.org/C95457728","wikidata":"https://www.wikidata.org/wiki/Q309","display_name":"History","level":0,"score":0.0},{"id":"https://openalex.org/C166957645","wikidata":"https://www.wikidata.org/wiki/Q23498","display_name":"Archaeology","level":1,"score":0.0},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000068717","descriptor_name":"Glatiramer Acetate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000276","descriptor_name":"Adjuvants, Immunologic","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000276","descriptor_name":"Adjuvants, Immunologic","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000893","descriptor_name":"Anti-Inflammatory Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D001379","descriptor_name":"Azathioprine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D003520","descriptor_name":"Cyclophosphamide","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007166","descriptor_name":"Immunosuppressive Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008775","descriptor_name":"Methylprednisolone","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D008942","descriptor_name":"Mitoxantrone","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D009103","descriptor_name":"Multiple Sclerosis","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D009103","descriptor_name":"Multiple Sclerosis","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D010455","descriptor_name":"Peptides","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D016756","descriptor_name":"Immunoglobulins, Intravenous","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D016899","descriptor_name":"Interferon-beta","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D020551","descriptor_name":"Pulse Therapy, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1159/000008084","doi":"https://doi.org/10.1159/000008084","is_oa":false,"landing_page_url":"https://doi.org/10.1159/000008084","pdf_url":null,"source":{"id":"https://openalex.org/S162735375","display_name":"European Neurology","issn_l":"0014-3022","issn":["0014-3022","1421-9913"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-3","vabb-shw"],"host_organization":"https://openalex.org/P4310317820","host_organization_name":"Karger Publishers","host_organization_lineage":["https://openalex.org/P4310317820"],"host_organization_lineage_names":["Karger Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Neurology","raw_type":"journal-article"},{"id":"pmid:10529535","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/10529535","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European neurology","raw_type":"Consensus Statement"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9940000176429749,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":51,"referenced_works":["https://openalex.org/W119906120","https://openalex.org/W1486269303","https://openalex.org/W1964331606","https://openalex.org/W1966298565","https://openalex.org/W1966968689","https://openalex.org/W1967507425","https://openalex.org/W1972012098","https://openalex.org/W1984478814","https://openalex.org/W1986524136","https://openalex.org/W1993267543","https://openalex.org/W1997444752","https://openalex.org/W2002309182","https://openalex.org/W2004312546","https://openalex.org/W2005506388","https://openalex.org/W2009680091","https://openalex.org/W2012054969","https://openalex.org/W2015342345","https://openalex.org/W2017285222","https://openalex.org/W2019507627","https://openalex.org/W2022525996","https://openalex.org/W2028844455","https://openalex.org/W2030784878","https://openalex.org/W2033375487","https://openalex.org/W2042983418","https://openalex.org/W2054710763","https://openalex.org/W2069886565","https://openalex.org/W2079367120","https://openalex.org/W2087589796","https://openalex.org/W2097669496","https://openalex.org/W2118629253","https://openalex.org/W2119168009","https://openalex.org/W2122894564","https://openalex.org/W2125422382","https://openalex.org/W2130355701","https://openalex.org/W2131585698","https://openalex.org/W2134685876","https://openalex.org/W2135080336","https://openalex.org/W2138831654","https://openalex.org/W2139367012","https://openalex.org/W2141824506","https://openalex.org/W2169098250","https://openalex.org/W2313649737","https://openalex.org/W2321043971","https://openalex.org/W2325038063","https://openalex.org/W2332846030","https://openalex.org/W2340533542","https://openalex.org/W2396431257","https://openalex.org/W2418906722","https://openalex.org/W2436455003","https://openalex.org/W2984556666","https://openalex.org/W4240901768"],"related_works":["https://openalex.org/W4255613694","https://openalex.org/W2051495894","https://openalex.org/W145182321","https://openalex.org/W1571291825","https://openalex.org/W2410340012","https://openalex.org/W2332923821","https://openalex.org/W1999046806","https://openalex.org/W4300004974"],"abstract_inverted_index":{"The":[0,21,43,121],"promising":[1],"results":[2,47],"of":[3,17,31,38,45,67,88,99,114,123,135,142],"several":[4],"multicenter":[5],"studies":[6],"during":[7],"the":[8,14,29,36,46,68,115,129,143],"last":[9],"few":[10],"years":[11],"have":[12],"improved":[13],"immunomodulatory":[15],"treatment":[16,117],"multiple":[18],"sclerosis":[19],"(MS).":[20],"different":[22],"compounds":[23],"tested":[24],"were":[25],"shown":[26,83],"to":[27,34,40,71,75,110,127],"reduce":[28],"number":[30],"relapses":[32],"and":[33,102],"modulate":[35],"course":[37],"disease":[39],"various":[41],"extents.":[42],"transition":[44],"obtained":[48],"in":[49,108,119,138],"therapeutic":[50],"trials":[51],"into":[52],"daily":[53],"clinical":[54],"practice":[55],"is":[56,126],"often":[57],"delayed":[58],"or":[59,65,151],"even":[60],"hampered":[61],"by":[62],"monetary":[63],"restrictions":[64],"reluctance":[66],"medical":[69],"community":[70],"adjust":[72],"their":[73],"approach":[74],"new":[76,133,154],"treatments.":[77],"After":[78],"an":[79],"initial":[80],"inquiry":[81],"had":[82],"that":[84],"less":[85],"than":[86],"50%":[87],"eligible":[89],"patients":[90],"received":[91],"any":[92],"active":[93],"immunomodulating":[94],"treatment,":[95],"a":[96,112,132,148],"consensus":[97,130],"group":[98],"Austrian,":[100],"German":[101],"Swiss":[103],"MS":[104],"societies":[105],"was":[106],"formed":[107],"order":[109],"prepare":[111],"report":[113,125,144],"current":[116],"options":[118],"MS.":[120,139],"aim":[122],"this":[124],"present":[128],"on":[131,147],"concept":[134],"escalating":[136],"immunotherapy":[137],"Future":[140],"updates":[141],"are":[145],"planned":[146],"yearly":[149],"basis":[150],"whenever":[152],"substantial":[153],"evidence":[155],"becomes":[156],"available.":[157]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2007348690","counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2015,"cited_by_count":2},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
